Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
1(10%)
Results Posted
0%(0 trials)
Terminated
2(20%)

Phase Distribution

Ph phase_1
1
10%
Ph phase_2
4
40%
Ph not_applicable
1
10%
Ph early_phase_1
4
40%

Phase Distribution

5

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
4(40.0%)
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
4(40.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

4 of 8 finished

Non-Completion Rate

50.0%

4 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(4)
Terminated(4)
Other(1)

Detailed Status

Completed4
Withdrawn2
Terminated2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Early Phase 14 (40.0%)
Phase 11 (10.0%)
Phase 24 (40.0%)
N/A1 (10.0%)

Trials by Status

unknown110%
completed440%
recruiting110%
withdrawn220%
terminated220%

Recent Activity

1 active trials
Showing 5 of 10
recruitingphase_2

Reverse HER2-negative Immune Resistant Breast Cancer

NCT06731140
completedearly_phase_1

Study to Determine Effect of Gentle Wounding to Stimulate Hair Follicle Neogenesis

NCT03491267
terminatedphase_2

NB2013-HR German (GPOH) / Dutch (DCOG) Trial

NCT02641782
unknownearly_phase_1

A Clinical Study Evaluating the Efficacy and Safety of Retinoic Acid in Patients With 15q11-q13 Duplication Syndrome

NCT05281965
completednot_applicable

Opsin Receptors in Melasma

NCT04417348
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT06731140Phase 2

Reverse HER2-negative Immune Resistant Breast Cancer

Recruiting
NCT03491267Early Phase 1

Study to Determine Effect of Gentle Wounding to Stimulate Hair Follicle Neogenesis

Completed
NCT02641782Phase 2

NB2013-HR German (GPOH) / Dutch (DCOG) Trial

Terminated
NCT05281965Early Phase 1

A Clinical Study Evaluating the Efficacy and Safety of Retinoic Acid in Patients With 15q11-q13 Duplication Syndrome

Unknown
NCT04417348Not Applicable

Opsin Receptors in Melasma

Completed
NCT03392623Early Phase 1

DNA Methylation in Malar Melasma and Its Change by Sunscreen, Retinoic Acid and Niacinamide.

Completed
NCT01275274Phase 2

Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens

Withdrawn
NCT01048086Phase 2

90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)

Withdrawn
NCT02497833Early Phase 1

Retinoic Acid Supplementation and Subjects With Hypercholesterolemia

Completed
NCT00533169Phase 1

ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma

Terminated

All 10 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
10